Anitua, Eduardo https://orcid.org/0000-0002-8386-5303
Tierno, Roberto https://orcid.org/0009-0005-5941-6718
Alkhraisat, Mohammad Hamdan https://orcid.org/0000-0003-4422-4527
Article History
Received: 21 July 2025
Accepted: 3 September 2025
First Online: 13 September 2025
Declarations
:
: The authors declare the following competing financial interests: Eduardo Anitua is the Scientific Director of BTI Biotechnology Institute and Roberto Tierno and Mohammad Hamdan Alkhraisat are scientists at BTI Biotechnology Institute, a dental implant company that investigates in the fields of oral implantology and PRGF-Endoret ® technology.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.